nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Somnolence—Thiotepa—sarcoma	0.0027	0.0027	CcSEcCtD
Metolazone—Dyspepsia—Thiotepa—sarcoma	0.00268	0.00268	CcSEcCtD
Metolazone—Decreased appetite—Thiotepa—sarcoma	0.00264	0.00264	CcSEcCtD
Metolazone—Thrombocytopenia—Vincristine—sarcoma	0.00264	0.00264	CcSEcCtD
Metolazone—Photosensitivity—Doxorubicin—sarcoma	0.00263	0.00263	CcSEcCtD
Metolazone—Decreased appetite—Dactinomycin—sarcoma	0.00262	0.00262	CcSEcCtD
Metolazone—Fatigue—Thiotepa—sarcoma	0.00262	0.00262	CcSEcCtD
Metolazone—Dysgeusia—Etoposide—sarcoma	0.00262	0.00262	CcSEcCtD
Metolazone—Fatigue—Dactinomycin—sarcoma	0.0026	0.0026	CcSEcCtD
Metolazone—Pain—Thiotepa—sarcoma	0.0026	0.0026	CcSEcCtD
Metolazone—Constipation—Thiotepa—sarcoma	0.0026	0.0026	CcSEcCtD
Metolazone—Back pain—Etoposide—sarcoma	0.00259	0.00259	CcSEcCtD
Metolazone—Purpura—Epirubicin—sarcoma	0.00259	0.00259	CcSEcCtD
Metolazone—Shock—Mitoxantrone—sarcoma	0.00258	0.00258	CcSEcCtD
Metolazone—Pain—Dactinomycin—sarcoma	0.00258	0.00258	CcSEcCtD
Metolazone—Vascular purpura—Doxorubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Metolazone—Muscle spasms—Etoposide—sarcoma	0.00257	0.00257	CcSEcCtD
Metolazone—Thrombocytopenia—Mitoxantrone—sarcoma	0.00257	0.00257	CcSEcCtD
Metolazone—Anorexia—Vincristine—sarcoma	0.00257	0.00257	CcSEcCtD
Metolazone—Lethargy—Epirubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Metolazone—Feeling abnormal—Thiotepa—sarcoma	0.00251	0.00251	CcSEcCtD
Metolazone—Anorexia—Mitoxantrone—sarcoma	0.0025	0.0025	CcSEcCtD
Metolazone—Hyponatraemia—Epirubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Metolazone—Feeling abnormal—Dactinomycin—sarcoma	0.00249	0.00249	CcSEcCtD
Metolazone—Gastrointestinal pain—Thiotepa—sarcoma	0.00249	0.00249	CcSEcCtD
Metolazone—Ill-defined disorder—Etoposide—sarcoma	0.00248	0.00248	CcSEcCtD
Metolazone—Anaemia—Etoposide—sarcoma	0.00247	0.00247	CcSEcCtD
Metolazone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00247	0.00247	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Vincristine—sarcoma	0.00246	0.00246	CcSEcCtD
Metolazone—Insomnia—Vincristine—sarcoma	0.00244	0.00244	CcSEcCtD
Metolazone—Paraesthesia—Vincristine—sarcoma	0.00242	0.00242	CcSEcCtD
Metolazone—Urticaria—Thiotepa—sarcoma	0.00242	0.00242	CcSEcCtD
Metolazone—Malaise—Etoposide—sarcoma	0.00241	0.00241	CcSEcCtD
Metolazone—Vertigo—Etoposide—sarcoma	0.00241	0.00241	CcSEcCtD
Metolazone—Abdominal pain—Thiotepa—sarcoma	0.0024	0.0024	CcSEcCtD
Metolazone—Leukopenia—Etoposide—sarcoma	0.0024	0.0024	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00239	0.00239	CcSEcCtD
Metolazone—Purpura—Doxorubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Metolazone—Abdominal pain—Dactinomycin—sarcoma	0.00239	0.00239	CcSEcCtD
Metolazone—Paraesthesia—Mitoxantrone—sarcoma	0.00236	0.00236	CcSEcCtD
Metolazone—Loss of consciousness—Etoposide—sarcoma	0.00235	0.00235	CcSEcCtD
Metolazone—Lethargy—Doxorubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Metolazone—Decreased appetite—Vincristine—sarcoma	0.00235	0.00235	CcSEcCtD
Metolazone—Cough—Etoposide—sarcoma	0.00234	0.00234	CcSEcCtD
Metolazone—Somnolence—Mitoxantrone—sarcoma	0.00234	0.00234	CcSEcCtD
Metolazone—Fatigue—Vincristine—sarcoma	0.00233	0.00233	CcSEcCtD
Metolazone—Hyponatraemia—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Metolazone—Dyspepsia—Mitoxantrone—sarcoma	0.00231	0.00231	CcSEcCtD
Metolazone—Hypertension—Etoposide—sarcoma	0.00231	0.00231	CcSEcCtD
Metolazone—Pain—Vincristine—sarcoma	0.00231	0.00231	CcSEcCtD
Metolazone—Constipation—Vincristine—sarcoma	0.00231	0.00231	CcSEcCtD
Metolazone—Dry skin—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Metolazone—Decreased appetite—Mitoxantrone—sarcoma	0.00228	0.00228	CcSEcCtD
Metolazone—Chest pain—Etoposide—sarcoma	0.00228	0.00228	CcSEcCtD
Metolazone—Orthostatic hypotension—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Metolazone—Hypokalaemia—Epirubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Metolazone—Fatigue—Mitoxantrone—sarcoma	0.00226	0.00226	CcSEcCtD
Metolazone—Discomfort—Etoposide—sarcoma	0.00225	0.00225	CcSEcCtD
Metolazone—Pain—Mitoxantrone—sarcoma	0.00225	0.00225	CcSEcCtD
Metolazone—Constipation—Mitoxantrone—sarcoma	0.00225	0.00225	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Metolazone—Hypersensitivity—Thiotepa—sarcoma	0.00224	0.00224	CcSEcCtD
Metolazone—Hypersensitivity—Dactinomycin—sarcoma	0.00222	0.00222	CcSEcCtD
Metolazone—Gastrointestinal pain—Vincristine—sarcoma	0.00221	0.00221	CcSEcCtD
Metolazone—Asthenia—Thiotepa—sarcoma	0.00218	0.00218	CcSEcCtD
Metolazone—Abdominal distension—Epirubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Metolazone—Asthenia—Dactinomycin—sarcoma	0.00217	0.00217	CcSEcCtD
Metolazone—Feeling abnormal—Mitoxantrone—sarcoma	0.00216	0.00216	CcSEcCtD
Metolazone—Pruritus—Thiotepa—sarcoma	0.00215	0.00215	CcSEcCtD
Metolazone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00215	0.00215	CcSEcCtD
Metolazone—Thrombocytopenia—Etoposide—sarcoma	0.00214	0.00214	CcSEcCtD
Metolazone—Abdominal pain—Vincristine—sarcoma	0.00213	0.00213	CcSEcCtD
Metolazone—Dry skin—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Metolazone—Pancreatitis—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Metolazone—Orthostatic hypotension—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Metolazone—Hypokalaemia—Doxorubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Metolazone—Urticaria—Mitoxantrone—sarcoma	0.00209	0.00209	CcSEcCtD
Metolazone—Anorexia—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Metolazone—Diarrhoea—Thiotepa—sarcoma	0.00208	0.00208	CcSEcCtD
Metolazone—Abdominal pain—Mitoxantrone—sarcoma	0.00208	0.00208	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Metolazone—Diarrhoea—Dactinomycin—sarcoma	0.00207	0.00207	CcSEcCtD
Metolazone—Dizziness—Thiotepa—sarcoma	0.00201	0.00201	CcSEcCtD
Metolazone—Abdominal distension—Doxorubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Metolazone—Hypersensitivity—Vincristine—sarcoma	0.00199	0.00199	CcSEcCtD
Metolazone—Photosensitivity reaction—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Metolazone—Paraesthesia—Etoposide—sarcoma	0.00196	0.00196	CcSEcCtD
Metolazone—Pancreatitis—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Metolazone—Hyperglycaemia—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Metolazone—Somnolence—Etoposide—sarcoma	0.00194	0.00194	CcSEcCtD
Metolazone—Hypersensitivity—Mitoxantrone—sarcoma	0.00194	0.00194	CcSEcCtD
Metolazone—Asthenia—Vincristine—sarcoma	0.00194	0.00194	CcSEcCtD
Metolazone—Vomiting—Thiotepa—sarcoma	0.00193	0.00193	CcSEcCtD
Metolazone—Drowsiness—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Metolazone—Vomiting—Dactinomycin—sarcoma	0.00192	0.00192	CcSEcCtD
Metolazone—Rash—Thiotepa—sarcoma	0.00192	0.00192	CcSEcCtD
Metolazone—Dermatitis—Thiotepa—sarcoma	0.00192	0.00192	CcSEcCtD
Metolazone—Headache—Thiotepa—sarcoma	0.00191	0.00191	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Metolazone—Rash—Dactinomycin—sarcoma	0.0019	0.0019	CcSEcCtD
Metolazone—Decreased appetite—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Metolazone—Asthenia—Mitoxantrone—sarcoma	0.00188	0.00188	CcSEcCtD
Metolazone—Fatigue—Etoposide—sarcoma	0.00188	0.00188	CcSEcCtD
Metolazone—Neuropathy peripheral—Epirubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Metolazone—Pain—Etoposide—sarcoma	0.00187	0.00187	CcSEcCtD
Metolazone—Constipation—Etoposide—sarcoma	0.00187	0.00187	CcSEcCtD
Metolazone—Diarrhoea—Vincristine—sarcoma	0.00185	0.00185	CcSEcCtD
Metolazone—Photosensitivity reaction—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Metolazone—Epistaxis—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Metolazone—Nausea—Thiotepa—sarcoma	0.00181	0.00181	CcSEcCtD
Metolazone—Feeling abnormal—Etoposide—sarcoma	0.0018	0.0018	CcSEcCtD
Metolazone—Hyperglycaemia—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Metolazone—Diarrhoea—Mitoxantrone—sarcoma	0.0018	0.0018	CcSEcCtD
Metolazone—Nausea—Dactinomycin—sarcoma	0.00179	0.00179	CcSEcCtD
Metolazone—Agranulocytosis—Epirubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Metolazone—Gastrointestinal pain—Etoposide—sarcoma	0.00179	0.00179	CcSEcCtD
Metolazone—Dizziness—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Metolazone—Drowsiness—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Metolazone—Neuropathy peripheral—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Metolazone—Urticaria—Etoposide—sarcoma	0.00174	0.00174	CcSEcCtD
Metolazone—Abdominal pain—Etoposide—sarcoma	0.00173	0.00173	CcSEcCtD
Metolazone—Hepatitis—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Metolazone—Vomiting—Vincristine—sarcoma	0.00172	0.00172	CcSEcCtD
Metolazone—Rash—Vincristine—sarcoma	0.0017	0.0017	CcSEcCtD
Metolazone—Dermatitis—Vincristine—sarcoma	0.0017	0.0017	CcSEcCtD
Metolazone—Headache—Vincristine—sarcoma	0.00169	0.00169	CcSEcCtD
Metolazone—Epistaxis—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Metolazone—Vomiting—Mitoxantrone—sarcoma	0.00167	0.00167	CcSEcCtD
Metolazone—Agranulocytosis—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Metolazone—Rash—Mitoxantrone—sarcoma	0.00166	0.00166	CcSEcCtD
Metolazone—Dermatitis—Mitoxantrone—sarcoma	0.00165	0.00165	CcSEcCtD
Metolazone—Headache—Mitoxantrone—sarcoma	0.00165	0.00165	CcSEcCtD
Metolazone—Erythema multiforme—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—sarcoma	0.00161	0.00161	CcSEcCtD
Metolazone—Tinnitus—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Metolazone—Nausea—Vincristine—sarcoma	0.0016	0.0016	CcSEcCtD
Metolazone—Hepatitis—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Metolazone—Asthenia—Etoposide—sarcoma	0.00157	0.00157	CcSEcCtD
Metolazone—Nausea—Mitoxantrone—sarcoma	0.00156	0.00156	CcSEcCtD
Metolazone—Chills—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Metolazone—Pruritus—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Metolazone—Erythema multiforme—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Metolazone—Diarrhoea—Etoposide—sarcoma	0.0015	0.0015	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Metolazone—Flatulence—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Metolazone—Tension—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Metolazone—Dysgeusia—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Metolazone—Nervousness—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Metolazone—Back pain—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Metolazone—Dizziness—Etoposide—sarcoma	0.00145	0.00145	CcSEcCtD
Metolazone—Muscle spasms—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Metolazone—Chills—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Metolazone—Vision blurred—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Metolazone—Ill-defined disorder—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Metolazone—Vomiting—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Metolazone—Anaemia—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Metolazone—Agitation—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Metolazone—Rash—Etoposide—sarcoma	0.00138	0.00138	CcSEcCtD
Metolazone—Dermatitis—Etoposide—sarcoma	0.00138	0.00138	CcSEcCtD
Metolazone—Headache—Etoposide—sarcoma	0.00137	0.00137	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Metolazone—Tension—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Metolazone—Malaise—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Metolazone—Vertigo—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Metolazone—Syncope—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Metolazone—Leukopenia—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Metolazone—Back pain—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Metolazone—Palpitations—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Metolazone—Loss of consciousness—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Metolazone—Cough—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Metolazone—Nausea—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Metolazone—Hypertension—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Metolazone—Arthralgia—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Metolazone—Chest pain—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Metolazone—Agitation—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Metolazone—Anxiety—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Metolazone—Discomfort—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Metolazone—Malaise—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Metolazone—Dry mouth—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Metolazone—Syncope—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Metolazone—Palpitations—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Metolazone—Loss of consciousness—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Metolazone—Cough—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Metolazone—Shock—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Metolazone—Thrombocytopenia—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Metolazone—Discomfort—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Metolazone—Anorexia—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Metolazone—Shock—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Metolazone—Thrombocytopenia—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Metolazone—Insomnia—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Metolazone—Paraesthesia—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Metolazone—Somnolence—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Metolazone—Anorexia—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Metolazone—Dyspepsia—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Metolazone—Decreased appetite—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Metolazone—Fatigue—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Metolazone—Pain—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Metolazone—Constipation—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Metolazone—Paraesthesia—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Metolazone—Feeling abnormal—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Metolazone—Gastrointestinal pain—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—sarcoma	0.000998	0.000998	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—sarcoma	0.000985	0.000985	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—sarcoma	0.000977	0.000977	CcSEcCtD
Metolazone—Urticaria—Epirubicin—sarcoma	0.000973	0.000973	CcSEcCtD
Metolazone—Pain—Doxorubicin—sarcoma	0.000969	0.000969	CcSEcCtD
Metolazone—Constipation—Doxorubicin—sarcoma	0.000969	0.000969	CcSEcCtD
Metolazone—Abdominal pain—Epirubicin—sarcoma	0.000968	0.000968	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—sarcoma	0.000934	0.000934	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000927	0.000927	CcSEcCtD
Metolazone—Hypersensitivity—Epirubicin—sarcoma	0.000902	0.000902	CcSEcCtD
Metolazone—Urticaria—Doxorubicin—sarcoma	0.0009	0.0009	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—sarcoma	0.000896	0.000896	CcSEcCtD
Metolazone—Asthenia—Epirubicin—sarcoma	0.000879	0.000879	CcSEcCtD
Metolazone—Pruritus—Epirubicin—sarcoma	0.000867	0.000867	CcSEcCtD
Metolazone—Diarrhoea—Epirubicin—sarcoma	0.000838	0.000838	CcSEcCtD
Metolazone—Hypersensitivity—Doxorubicin—sarcoma	0.000835	0.000835	CcSEcCtD
Metolazone—Asthenia—Doxorubicin—sarcoma	0.000813	0.000813	CcSEcCtD
Metolazone—Dizziness—Epirubicin—sarcoma	0.00081	0.00081	CcSEcCtD
Metolazone—Pruritus—Doxorubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Metolazone—Vomiting—Epirubicin—sarcoma	0.000779	0.000779	CcSEcCtD
Metolazone—Diarrhoea—Doxorubicin—sarcoma	0.000775	0.000775	CcSEcCtD
Metolazone—Rash—Epirubicin—sarcoma	0.000772	0.000772	CcSEcCtD
Metolazone—Dermatitis—Epirubicin—sarcoma	0.000772	0.000772	CcSEcCtD
Metolazone—Headache—Epirubicin—sarcoma	0.000767	0.000767	CcSEcCtD
Metolazone—Dizziness—Doxorubicin—sarcoma	0.000749	0.000749	CcSEcCtD
Metolazone—Nausea—Epirubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Metolazone—Vomiting—Doxorubicin—sarcoma	0.000721	0.000721	CcSEcCtD
Metolazone—Rash—Doxorubicin—sarcoma	0.000715	0.000715	CcSEcCtD
Metolazone—Dermatitis—Doxorubicin—sarcoma	0.000714	0.000714	CcSEcCtD
Metolazone—Headache—Doxorubicin—sarcoma	0.00071	0.00071	CcSEcCtD
Metolazone—Nausea—Doxorubicin—sarcoma	0.000673	0.000673	CcSEcCtD
